GLP-1s are expected to face disruption, although the nature of this disruption is unclear. The market for GLP-1s is reportedly rising, with potential implications for the pharmaceutical industry, including a possible patent cliff and increased drug plan costs. The impact of GLP-1s extends beyond the pharmaceutical industry, with potential effects on various sectors, but the specifics of the disruption and its consequences are not well defined.